https://www.selleckchem.com/products/tph104m.html
Significant loss of mean RNFL (from 100.79±16.05μm to 89.96±13.79μm) and GCIPL thickness (from 83.1±5.60μm to 79.85±6.45μm) was observed at 6months (p=0.001 for both). Patients with subclinical toxicity had significantly greater damage in temporal RNFL quadrant, supero-nasal and infero-nasal GCIPL sectors compared with others. The incidence of clinical EMB optic neuropathy was 2%, though subclinical damage in the form of increase in VER latency, and decrease in RNFL and GCIPL on OCT was seen in 46% eyes. The incidence of clinical EM